Product Overview
Our products and services include:
Pharmacor
Analyzing and Forecasting the Commercial Outlook for Drugs on the Market and in Research and Development
Pharmacor, Decision Resources' flagship advisory service, assesses the overall clinical and commercial environment for drug therapies within a disease indication.
Emerging Markets
The Ultimate Analysis of New and Growing Pharmaceutical Markets
Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis.
DecisionBase
Empowering Decision Makers with Robust Interactive Data and Analysis
DecisionBase is an interactive decision tool that allows you to measure and compare commercial opportunities, compound attributes and treatment protocols.
PatientBase
Customizable Epidemiological Data
PatientBase is a flexible data tool set that you can easily manipulate to create custom epidemiological projections of key patient segments.
Physician & Payer Forum
Primary Market Research at a Multi-Client Price
Physician & Payer Forum includes direct feedback from high-volume-prescribing primary care physicians, viewpoints from the managed care sector and insight into the impact of events on specific markets.
Pharmaview
Invaluable Corporate and Commercial Analysis of the Biopharmaceutical Industry
Pharmaview offers all the insight you need to understand how each player in the biopharmaceutical industry functions. Financial information, individual company breakdown, therapeutic analysis and impact of major events are all contained in a subscription to Pharmaview.
Analogue Tool
Access Extensive Product Analogues to Understand Market Opportunity
The Analogue Tool is a dynamic, interactive web-based platform that allows users to search for product analogues based on a range of metrics.
Innovative R&D and Dealmaking Opportunities
Pipeline insights and analysis to inform licensing, partnering and acquisition opportunities
Decision Resources’ Innovative R&D and Dealmaking Opportunities series is an essential tool for pharmaceutical business development teams. Each therapeutic-area focused report examines opportunities to access, license or acquire novel drug candidates and technologies.
Market Access Tracker
Timely Insights into a Fast-Changing Environment
Market access is increasingly critical to a drug’s commercial success, but it’s a challenge as payers are increasing prelaunch and post-marketing obstacles and the market access environment is in constant flux. Decision Resources’ Market Access Tracker service explains the challenges and opportunities to gaining favorable market access terms.
Niche Markets and Rare Diseases
Analyzing the Competitive Landscape for Drugs Treating Niche Markets and Rare Diseases
Decision Resources expands its analysis of the commercial outlook of drugs on the market and in development with its Niche Markets and Rare Diseases service.
Disease-Specific Reports
Decision Resources produces more than 150 reports each year. They span a broad array of subjects, ranging from specific diseases or research pathways to analysis of key issues facing the biopharmaceutical industry today.
Consulting & Advisory Services
Decision Resources Consulting group is dedicated to helping pharmaceutical, biotech and other healthcare companies develop true competitive advantage.
Epidemiology & Forecasting
Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.